Clinical trials recruiting for Atrial Fibrillation New Onset
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Amiodarone Hydrochloride 200 MG | 1 |
| Empagliflozin 10 MG | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Missouri | 1 |
Top cities
Self-screener
Recruiting trials
- BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
- EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source
- Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
- Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial
- Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion
Related conditions
Trials recruiting for Atrial Fibrillation New Onset often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Atrial Fibrillation New Onset trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.